1	Polymorphic	polymorphic	_	_	_	_	_	_	_
2	nucleotides	nucleotide	_	_	_	_	_	_	_
3	within	within	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	IL-4	il-4	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	mediate	mediate	_	_	_	_	_	_	_
10	overexpression	overexpression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	gene	gene	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Atopy	Atopy	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	which	which	_	_	_	_	_	_	_
4	predisposes	predispose	_	_	_	_	_	_	_
5	individuals	individual	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	develop	develop	_	_	_	_	_	_	_
8	asthma	asthma	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	severe	severe	_	_	_	_	_	_	_
11	systemic	systemic	_	_	_	_	_	_	_
12	anaphylaxis	anaphylaxis	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	atopic	atopic	_	_	_	_	_	_	_
16	dermatitis	dermatitis	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	usually	usually	_	_	_	_	_	_	_
20	associated	associate	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	dramatically	dramatically	_	_	_	_	_	_	_
23	elevated	elevated	_	_	_	_	_	_	_
24	total	total	_	_	_	_	_	_	_
25	serum	serum	_	_	_	_	_	_	_
26	IgE	ige	_	_	_	_	_	_	_
27	levels	level	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	is	be	_	_	_	_	_	_	_
30	thought	think	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	be	be	_	_	_	_	_	_	_
33	controlled	control	_	_	_	_	_	_	_
34	by	by	_	_	_	_	_	_	_
35	a	a	_	_	_	_	_	_	_
36	major	major	_	_	_	_	_	_	_
37	susceptibility	susceptibility	_	_	_	_	_	_	_
38	gene	gene	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	multiple	multiple	_	_	_	_	_	_	_
41	minor	minor	_	_	_	_	_	_	_
42	susceptibility	susceptibility	_	_	_	_	_	_	_
43	genes	gene	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	recent	recent	_	_	_	_	_	_	_
3	sib-pair	sib-pair	_	_	_	_	_	_	_
4	analysis	analysis	_	_	_	_	_	_	_
5	revealed	reveal	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	tight	tight	_	_	_	_	_	_	_
8	linkage	linkage	_	_	_	_	_	_	_
9	between	between	_	_	_	_	_	_	_
10	markers	marker	_	_	_	_	_	_	_
11	on	on	_	_	_	_	_	_	_
12	5q31.1	5q31.1	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	major	major	_	_	_	_	_	_	_
16	susceptibility	susceptibility	_	_	_	_	_	_	_
17	gene	gene	_	_	_	_	_	_	_
18	controlling	control	_	_	_	_	_	_	_
19	total	total	_	_	_	_	_	_	_
20	serum	serum	_	_	_	_	_	_	_
21	IgE	ige	_	_	_	_	_	_	_
22	levels	level	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Due	due	_	_	_	_	_	_	_
2	to	to	_	_	_	_	_	_	_
3	its	its	_	_	_	_	_	_	_
4	location	location	_	_	_	_	_	_	_
5	within	within	_	_	_	_	_	_	_
6	this	this	_	_	_	_	_	_	_
7	cluster	cluster	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	its	its	_	_	_	_	_	_	_
10	biologic	biologic	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	Ig	ig	_	_	_	_	_	_	_
14	class	class	_	_	_	_	_	_	_
15	switching	switching	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	Th2	th2	_	_	_	_	_	_	_
18	cell	cell	_	_	_	_	_	_	_
19	differentiation	differentiation	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	IL-4	il-4	_	_	_	_	_	_	_
23	gene	gene	_	_	_	_	_	_	_
24	has	have	_	_	_	_	_	_	_
25	emerged	emerge	_	_	_	_	_	_	_
26	as	as	_	_	_	_	_	_	_
27	one	one	_	_	_	_	_	_	_
28	major	major	_	_	_	_	_	_	_
29	candidate	candidate	_	_	_	_	_	_	_
30	for	for	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	atopy	atopy	_	_	_	_	_	_	_
33	gene	gene	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	one	one	_	_	_	_	_	_	_
3	model	model	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	polymorphisms	polymorphism	_	_	_	_	_	_	_
6	within	within	_	_	_	_	_	_	_
7	IL-4	il-4	_	_	_	_	_	_	_
8	regulatory	regulatory	_	_	_	_	_	_	_
9	elements	element	_	_	_	_	_	_	_
10	might	might	_	_	_	_	_	_	_
11	result	result	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	overexpression	overexpression	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	gene	gene	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	amplifying	amplify	_	_	_	_	_	_	_
19	Th2	th2	_	_	_	_	_	_	_
20	cell	cell	_	_	_	_	_	_	_
21	differentiation	differentiation	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	class	class	_	_	_	_	_	_	_
24	switching	switching	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	IgE	IgE	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	support	support	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	model	model	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	we	we	_	_	_	_	_	_	_
8	report	report	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	IL-4	il-4	_	_	_	_	_	_	_
13	promoter	promoter	_	_	_	_	_	_	_
14	exists	exist	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	multiple	multiple	_	_	_	_	_	_	_
17	allelic	allelic	_	_	_	_	_	_	_
18	forms	form	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	exhibit	exhibit	_	_	_	_	_	_	_
21	distinct	distinct	_	_	_	_	_	_	_
22	transcriptional	transcriptional	_	_	_	_	_	_	_
23	activities	activity	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	IL-4-positive	il-4-positive	_	_	_	_	_	_	_
26	T	t	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	particular	particular	_	_	_	_	_	_	_
3	allele	allele	_	_	_	_	_	_	_
4	has	have	_	_	_	_	_	_	_
5	an	an	_	_	_	_	_	_	_
6	unusually	unusually	_	_	_	_	_	_	_
7	high	high	_	_	_	_	_	_	_
8	transcriptional	transcriptional	_	_	_	_	_	_	_
9	activity	activity	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	nucleotide	nucleotide	_	_	_	_	_	_	_
3	substitution	substitution	_	_	_	_	_	_	_
4	within	within	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	recently	recently	_	_	_	_	_	_	_
7	described	describe	_	_	_	_	_	_	_
8	OAP40	oap40	_	_	_	_	_	_	_
9	element	element	_	_	_	_	_	_	_
10	located	located	_	_	_	_	_	_	_
11	just	just	_	_	_	_	_	_	_
12	upstream	upstream	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	an	an	_	_	_	_	_	_	_
15	NF-AT	NF-AT	_	_	_	_	_	_	_
16	site	site	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	P	p	_	_	_	_	_	_	_
19	sequence	sequence	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	appears	appear	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	be	be	_	_	_	_	_	_	_
24	largely	largely	_	_	_	_	_	_	_
25	responsible	responsible	_	_	_	_	_	_	_
26	for	for	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	increased	increase	_	_	_	_	_	_	_
29	promotor	promotor	_	_	_	_	_	_	_
30	strength	strength	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	this	this	_	_	_	_	_	_	_
33	particular	particular	_	_	_	_	_	_	_
34	allelic	allelic	_	_	_	_	_	_	_
35	form	form	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	IL-4	il-4	_	_	_	_	_	_	_
39	promoter	promoter	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	EMSAs	EMSA	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	substitution	substitution	_	_	_	_	_	_	_
6	results	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	markedly	markedly	_	_	_	_	_	_	_
10	enhanced	enhance	_	_	_	_	_	_	_
11	affinity	affinity	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	sequence-specific	sequence-specific	_	_	_	_	_	_	_
14	complexes	complex	_	_	_	_	_	_	_
15	exhibiting	exhibit	_	_	_	_	_	_	_
16	an	an	_	_	_	_	_	_	_
17	AP-1	ap-1	_	_	_	_	_	_	_
18	specificity	specificity	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	identification	identification	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	allelic	allelic	_	_	_	_	_	_	_
5	nucleotides	nucleotide	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	results	result	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	overexpression	overexpression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	IL-4	il-4	_	_	_	_	_	_	_
14	gene	gene	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	provides	provide	_	_	_	_	_	_	_
17	specific	specific	_	_	_	_	_	_	_
18	targets	target	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	comprehensive	comprehensive	_	_	_	_	_	_	_
22	screening	screening	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	atopic	atopic	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	nonatopic	nonatopic	_	_	_	_	_	_	_
27	individuals	individual	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	may	may	_	_	_	_	_	_	_
30	provide	provide	_	_	_	_	_	_	_
31	a	a	_	_	_	_	_	_	_
32	clue	clue	_	_	_	_	_	_	_
33	for	for	_	_	_	_	_	_	_
34	genetic	genetic	_	_	_	_	_	_	_
35	predisposition	predisposition	_	_	_	_	_	_	_
36	for	for	_	_	_	_	_	_	_
37	atopy	atopy	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

